EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

QingChang-XiaoPi decoction ameliorates intestinal inflammation of ulcerative colitis by regulating the pathogenicity of Th17 cells

Rui Jia, Huan Zheng, Siya Li, Weihuan Chen, Yuanming Yang, Haomeng Wu, Haiming Chen, Shumin Qin, Shaogang Huang

Phytomedicine · 2024-09 · 132 · 155779

DOI: 10.1016/j.phymed.2024.155779 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytomedicine, 2024-09. Verfasst von Rui Jia und 8 weiteren Autor:innen. Beteiligte Einrichtung: The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou 510120, PR China. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Th17 Cells, Drugs, Chinese Herbal, Dextran Sulfate. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: QingChang-XiaoPi Decoction (QCXPY), a Chinese herbal prescription, has been employed in the treatment of ulcerative colitis (UC) in China. However, its molecular mechanism of action in UC remains unclear. PURPOSE: To elucidate the therapeutic effects of QCXPY against UC and reveal its mechanism of action. STUDY DESIGN: We conducted a single-arm observation to evaluate the clinical efficacy of QCXPY in patients with mild-to-moderate UC. Inclusion and exclusion criteria were established to ensure the eligibility of participants, with a focus on excluding patients with specific conditions or complications that could confound the results. METHODS: The expression of inflammatory factors in patients' serum was detected using a Luminex assay. The main components of QCXPY were identified using UHPLC-Q-TOF-MS. Network pharmacology was employed to predict potential therapeutic targets and their mechanisms of action. The efficacy of QCXPY was evaluated using a dextran sulfate sodium (DSS)-induced mouse model. Disease activity index (DAI), histopathological score, cytokine detection by ELISA, T-helper 17 (Th17) cell proportion by flow cytometry, expression of the IL-23/IL-17 axis, and changes in the levels of its downstream effectors were detected by immunohistochemistry, immunofluorescence, and western blotting. RESULTS: QCXPY could alleviate the symptoms of diarrhea, abdominal pain, abdominal distension, and purulent stool in patients with mild-to-moderate UC. Moreover, it reduced the expression of IL-6, IL-17, and IL-23 in serum; alleviated DSS-induced experimental colitis in mice; reduced DAI, pathological scores, and the expressions of IL-6, IL-17, and IL-23 in colon tissue; and decreased the proportion of pathogenic Th17 cells and the expression of STAT3 and phospho-STAT3. CONCLUSION: This study confirmed for the first time that QCXPY could alleviate intestinal symptoms, reduce the levels of serum inflammatory factors, and improve the quality of life of patients with mild-to-moderate UC. Its mechanism of action may involve reducing the secretion of inflammatory cytokines, moderating the pathogenicity of Th17 cells, and inhibiting STAT3 phosphorylation, thereby alleviating intestinal inflammation in UC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colitis, UlcerativeTh17 CellsDrugs, Chinese HerbalDextran SulfateDisease Models, AnimalSTAT3 Transcription FactorAnimalsHumansMaleFemaleAdultMiceMiddle AgedInterleukin-17Interleukin-23Mice, Inbred C57BLNetwork PharmacologyYoung AdultCytokines

Stichwörter der Autor:innen

Chinese medicineIL-23/IL-17IL-6/p-STAT3Th17Ulcerative colitis

Substanzen

Drugs, Chinese HerbalDextran SulfateSTAT3 Transcription FactorInterleukin-17Interleukin-23Cytokines

Autor:innen und Institutionen

  • The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou 510120, PR China.
  • The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou 510120, PR China; The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510120, PR China; State Key Labo…
  • The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510120, PR China.
  • The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510120, PR China; Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease Research, Guangzhou 510120, PR China; Gua…

Zitieren

APA

Jia, R., Zheng, H., Li, S., Chen, W., Yang, Y., Wu, H., Chen, H., Qin, S., & Huang, S. (2024). QingChang-XiaoPi decoction ameliorates intestinal inflammation of ulcerative colitis by regulating the pathogenicity of Th17 cells. Phytomedicine, 132, 155779. https://doi.org/10.1016/j.phymed.2024.155779

Vancouver

Jia R, Zheng H, Li S, Chen W, Yang Y, Wu H, et al. QingChang-XiaoPi decoction ameliorates intestinal inflammation of ulcerative colitis by regulating the pathogenicity of Th17 cells. Phytomedicine. 2024;132:155779. doi:10.1016/j.phymed.2024.155779

BibTeX
@article{Jia2024,
  author = {Jia, Rui and Zheng, Huan and Li, Siya and Chen, Weihuan and Yang, Yuanming and Wu, Haomeng and Chen, Haiming and Qin, Shumin and Huang, Shaogang},
  title = {QingChang-XiaoPi decoction ameliorates intestinal inflammation of ulcerative colitis by regulating the pathogenicity of Th17 cells},
  journal = {Phytomedicine},
  year = {2024},
  volume = {132},
  pages = {155779},
  doi = {10.1016/j.phymed.2024.155779}
}
Kostenlos starten →